Schedule a COVID vaccine or booster appointment:
Log in to myPennMedicine or call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Sees patients age 18 and up
Sees patients age 18 and up
Penn Presbyterian Medical Center
240 Medical Office Building
51 N. 39th Street
Philadelphia, PA 19104
A facility of Penn Presbyterian Medical Center
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown above from our internal platform, PMX Feedback. Responses are measured on a scale of 1 to 5 with 5 being the best score. Scores reflect either the most recent 12 months of surveys or the most recent 30 surveys overall. Data is updated monthly and comments remain on the profile for 12 months.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Patients that are treated in outpatient or hospital environments may receive different surveys.
1. Medical Education - Involvement in all aspects of medical training at Penn School of Medicine and Penn Graduate Medical Education. Areas of expertise include novel curriculum development including enhanced multidisciplinary teaching in palliative care, critical care, and glomerular diseases. Additional efforts have focused on increasing minority trainee representation within nephrology.2. Kidney living donor evaluation and outcomes - Expansion of non-directed donation through collaboration with the National Kidney Registry. Quality improvement efforts for more streamlined and donor-centered care approaches, leading to improved donor experience and improved efficiency of living donor evaluation processes.3. Influence of dietary patterns and CKD management - This area of research includes the association of micronutrient content and clinical outcomes in chronic kidney disease and healthy individuals. She is interested in the clinical outcomes associated with potassium, sodium, and the ratio of these two electrolytes in terms of cardiovascular and kidney disease clinical outcomes and has published in this area. 4. Contrast associated acute kidney injury - Involvement in both scholarly activity and quality improvement of assessment and management of IV contrast nephrotoxicity.
Kearney D, Leonberg-Yoo A, Cohen R.: Frequent vascular access thrombosis in a patient with end stage kidney disease on hemodialysis Semin Dial : 2023.
Leonberg-Yoo AK, Gilbert SJ.: Teaching Conservative Kidney Management and Other Palliative Care Skills in Nephrology Fellowships Semin Nephrol 43 : 151396,2023.
Spiardi R, Shah S, Leonberg-Yoo A.: A Patient With Polyuria and Hypercalcemia Am J Kidney Dis 79 (4): A14-A15,2022.
Gelfand SL, Jain K, Brewster UC, Leonberg-Yoo AK.: Combined Nephrology and Palliative Medicine Fellowship Training: A Breath of Fresh AIRE Am J Kidney Dis S0272-6386 (21): 00881-7,2021.
Mathews KS, Soh H, Shaefi S, Wang W, Bose S, Coca S, Gupta S, Hayek SS, Srivastava A, Brenner SK, Radbel J, Green A, Sutherland A, Leonberg-Yoo A, Shehata A, Schenck EJ, Short SAP, Hernán MA, Chan L, Leaf DE; Study of the Treatment and Outcomes in Critically Ill Patients with Coronavirus Disease (STOP-COVID) Investigators.: Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure Crit Care Med : 1026-1037,2021.
Bansal N, Hall YN, Sambandam KK, Leonberg-Yoo AK.: Lessons Learned: Nephrology Training Program Adaptation in the Time of COVID Am J Kidney Dis 78 (1): 9-12,2021.
Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI.: Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review Am J Kidney Dis 77 : 517-528,2021.
Shaefi S, Brenner SK, Gupta S, O'Gara BP, Krajewski ML, Charytan DM, Chaudhry S, Mirza SH, Peev V, Anderson M, Bansal A, Hayek SS, Srivastava A, Mathews KS, Johns TS, Leonberg-Yoo A, Green A, Arunthamakun J, Wille KM, Shaukat T, Singh H, Admon AJ, Semler MW, Hernán MA, Mueller AL, Wang W, Leaf DE; STOP-COVID Investigators.: Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 Intensive Care Med 47 : 208-221,2021.
Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Finkel D, Green A, Mallappallil M, Faugno AJ, Zhang J, Velez JCQ, Shaefi S, Parikh CR, Charytan DM, Athavale AM, Friedman AN, Redfern RE, Short SAP, Correa S, Pokharel KK, Admon AJ, Donnelly JP, Gershengorn HB, Douin DJ, Semler MW, Hernán MA, Leaf DE; STOP-COVID Investigators.: Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 JAMA Intern Med 181 : 41-51,2021.
Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE; and the STOP-COVID Investigators.: AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19 J Am Soc Nephrol 32 : 161-176,2021.
Penn Presbyterian Medical Center51 N. 39th StreetMedical Office Building, Suite 240
Patient appointments: 800-789-7366